Deltagen Inc. (OTCPK: DGEN)
Health Care · Life Sciences Tools & Services · US
$—
— today · — 1Y
Deltagen Inc. (OTCPK: DGEN) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $33.00 and employs 0 people.
trading between 0.00 and 0.00.
Tweenvest scores Deltagen Inc. across four factors: quality 56/100, value 51/100. Its strongest factor is quality.
DGEN price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $33.00
- Revenue (TTM)
- $770.00K
- P/E
- —
- EPS
- —
- Dividend yield
- —
- Beta (5Y)
- 69.84
- 52-week high
- $0.00
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 32.57M
- Employees
- 0
- Next earnings
- —
About Deltagen Inc.
Deltagen Inc. provides drug discovery tools and services to the biopharmaceutical industry. The company offers a suite of programs designed to enhance the efficiency of drug discovery, including access to biological models, as well as small-molecule and secreted protein drug targets. It also provides target validation data in the areas of immunology and metabolic diseases. The company was incorporated in 1999 and is headquartered in San Mateo, California.
- ISIN
- US24783R1032
- Founded
- 1999
- Listed since
- Aug 3, 2000
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Thermo Fisher Scientific Inc.NYSE: TMO | $232.67B | $629.27 | +0.27% |
| Danaher CorporationNYSE: DHR | $153.85B | $218.85 | +1.36% |
| WuXi AppTec Co., Ltd.SHSE: 603259 | $72.12B | CN¥162.86 | -3.00% |
| Samsung Biologics Co.,Ltd.KOSE: A207940 | $51.75B | ₩1,551,000.00 | +0.19% |
| Lonza Group AGSWX: LONN | $51.61B | CHF592.20 | +1.09% |
| Agilent Technologies, Inc.NYSE: A | $44.91B | $159.00 | +1.73% |
| IQVIA Holdings Inc.NYSE: IQV | $42.77B | $259.82 | +1.47% |
| Waters CorporationNYSE: WAT | $40.35B | $410.70 | +1.49% |
Figures last refreshed Aug 18, 2026.